Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| alpha-Fetoproteins | 1 | 2024 | 46 | 0.830 |
Why?
|
| Fetal Movement | 1 | 2020 | 4 | 0.640 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2020 | 4 | 0.640 |
Why?
|
| Fetomaternal Transfusion | 1 | 2020 | 3 | 0.640 |
Why?
|
| Fetal Monitoring | 1 | 2020 | 19 | 0.630 |
Why?
|
| Heart Rate, Fetal | 1 | 2020 | 16 | 0.630 |
Why?
|
| Fetal Membranes, Premature Rupture | 3 | 2003 | 19 | 0.520 |
Why?
|
| Streptococcal Infections | 2 | 2011 | 57 | 0.470 |
Why?
|
| Obstetrics | 2 | 2013 | 123 | 0.400 |
Why?
|
| Pregnancy | 12 | 2024 | 3240 | 0.400 |
Why?
|
| Patient Simulation | 2 | 2013 | 51 | 0.380 |
Why?
|
| Streptococcus anginosus | 1 | 2011 | 1 | 0.360 |
Why?
|
| Parotid Diseases | 1 | 2011 | 5 | 0.360 |
Why?
|
| Obstetric Labor Complications | 1 | 2011 | 34 | 0.350 |
Why?
|
| Models, Anatomic | 1 | 2011 | 93 | 0.350 |
Why?
|
| Computer-Assisted Instruction | 1 | 2011 | 48 | 0.350 |
Why?
|
| Abscess | 1 | 2011 | 95 | 0.340 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2011 | 56 | 0.340 |
Why?
|
| Gynecology | 1 | 2011 | 130 | 0.310 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2011 | 220 | 0.290 |
Why?
|
| Clinical Competence | 2 | 2013 | 854 | 0.250 |
Why?
|
| Infant, Newborn | 3 | 2024 | 2614 | 0.240 |
Why?
|
| Defensins | 1 | 2003 | 5 | 0.210 |
Why?
|
| Lactoferrin | 1 | 2003 | 11 | 0.210 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2024 | 71 | 0.200 |
Why?
|
| Chorioamnionitis | 1 | 2003 | 23 | 0.200 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 96 | 0.190 |
Why?
|
| Labor, Induced | 1 | 2002 | 32 | 0.190 |
Why?
|
| Neutrophils | 1 | 2003 | 332 | 0.180 |
Why?
|
| Cardiotocography | 1 | 2020 | 7 | 0.160 |
Why?
|
| Infant, Premature | 1 | 2020 | 308 | 0.130 |
Why?
|
| Female | 12 | 2024 | 50031 | 0.130 |
Why?
|
| Ampicillin | 1 | 1996 | 16 | 0.130 |
Why?
|
| Streptococcus agalactiae | 1 | 1996 | 13 | 0.130 |
Why?
|
| Prenatal Diagnosis | 3 | 2007 | 110 | 0.120 |
Why?
|
| Prenatal Care | 1 | 1996 | 84 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2005 | 155 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1996 | 127 | 0.110 |
Why?
|
| Teratoma | 2 | 2005 | 58 | 0.110 |
Why?
|
| Postpartum Hemorrhage | 1 | 2013 | 28 | 0.100 |
Why?
|
| Humans | 13 | 2024 | 96109 | 0.100 |
Why?
|
| United States | 2 | 2020 | 7768 | 0.100 |
Why?
|
| Gestational Age | 2 | 2003 | 343 | 0.090 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2011 | 5 | 0.090 |
Why?
|
| Sialadenitis | 1 | 2011 | 10 | 0.090 |
Why?
|
| Ciprofloxacin | 1 | 2011 | 25 | 0.090 |
Why?
|
| Parotid Gland | 1 | 2011 | 26 | 0.090 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 79 | 0.090 |
Why?
|
| Masks | 1 | 2011 | 31 | 0.090 |
Why?
|
| Adult | 8 | 2020 | 28722 | 0.090 |
Why?
|
| Polysomnography | 1 | 2011 | 155 | 0.080 |
Why?
|
| Pressure | 1 | 2011 | 175 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2011 | 126 | 0.080 |
Why?
|
| Pregnancy Outcome | 3 | 2007 | 273 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 1773 | 0.070 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2007 | 9 | 0.060 |
Why?
|
| Fetal Therapies | 1 | 2007 | 6 | 0.060 |
Why?
|
| Disease Progression | 1 | 2011 | 1561 | 0.060 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2007 | 14 | 0.060 |
Why?
|
| Internship and Residency | 2 | 2013 | 1134 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 847 | 0.060 |
Why?
|
| Lymphatic System | 1 | 2005 | 55 | 0.060 |
Why?
|
| Fetal Diseases | 1 | 2004 | 81 | 0.050 |
Why?
|
| Airway Obstruction | 1 | 2005 | 117 | 0.050 |
Why?
|
| Spinal Neoplasms | 1 | 2005 | 131 | 0.050 |
Why?
|
| Pregnancy in Diabetics | 1 | 2004 | 41 | 0.050 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2007 | 217 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 424 | 0.050 |
Why?
|
| Leg | 1 | 2004 | 143 | 0.050 |
Why?
|
| Cytoplasmic Granules | 1 | 2003 | 99 | 0.050 |
Why?
|
| Abdomen | 1 | 2004 | 127 | 0.050 |
Why?
|
| Cervical Vertebrae | 1 | 2005 | 232 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2004 | 238 | 0.050 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2004 | 149 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 2002 | 124 | 0.050 |
Why?
|
| Placenta | 1 | 2003 | 191 | 0.040 |
Why?
|
| Probability | 1 | 2002 | 365 | 0.040 |
Why?
|
| Time Factors | 2 | 2003 | 5580 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2002 | 501 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2001 | 285 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 2039 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2002 | 1010 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2005 | 3639 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 1996 | 48 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2001 | 854 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 1996 | 1791 | 0.020 |
Why?
|
| Male | 2 | 2011 | 45865 | 0.020 |
Why?
|
| Prospective Studies | 1 | 1996 | 4671 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2007 | 1546 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 453 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2007 | 9175 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2007 | 10287 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2777 | 0.010 |
Why?
|